Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2019 07:00 ET | Source: Summit Therapeutics plc

Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Presents In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotic at ASM/ESCMID Conference New Mechanism Antibiotic...
June 20, 2019 07:00 ET | Source: Summit Therapeutics plc

Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019 Oxford, UK, and Cambridge, MA, US,...
June 18, 2019 07:00 ET | Source: Summit Therapeutics plc

Increased BARDA Award and Option Exercise

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Announces BARDA Increases Award for Ridinilazole Clinical and Regulatory Development to up to $63.7 Million and Exercises Next Contract...
June 12, 2019 07:00 ET | Source: Summit Therapeutics plc

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019

Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019 Oxford, UK,...